TEVA PHARMACEUTICALS USA, INC.

Federal contract awards won by TEVA PHARMACEUTICALS USA, INC. (UEI NEN9A34LRHJ5), 2021–2026 — public record from USAspending.

Showing awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

287
awards
0
expiring in 12 months
1
agency

Agencies buying from TEVA PHARMACEUTICALS USA, INC.

Awards

8512184053!ADENOVIRUS TYPE 4 A
Department of Defense · $515,290 · Jun 16, 2026
8512184059!ADENOVIRUS TYPE 4 A
Department of Defense · $343,526 · Jun 16, 2026
8512183579!ADENOVIRUS TYPE 4 A
Department of Defense · $687,053 · Jun 16, 2026
8512183572!ADENOVIRUS TYPE 4 A
Department of Defense · $343,526 · Jun 16, 2026
8512183571!ADENOVIRUS TYPE 4 A
Department of Defense · $343,526 · Jun 16, 2026
8512183483!ADENOVIRUS TYPE 4 A
Department of Defense · $1,030,579 · Jun 16, 2026
8512183485!ADENOVIRUS TYPE 4 A
Department of Defense · $515,290 · Jun 16, 2026
8512183379!ADENOVIRUS TYPE 4 A
Department of Defense · $1,202,342 · Jun 16, 2026
8512097273!ADENOVIRUS TYPE 4 A
Department of Defense · $343,526 · May 11, 2026
8512097278!ADENOVIRUS TYPE 4 A
Department of Defense · $687,053 · May 11, 2026
8512097239!ADENOVIRUS TYPE 4 A
Department of Defense · $1,030,579 · May 11, 2026
8512097415!ADENOVIRUS TYPE 4 A
Department of Defense · $343,526 · May 11, 2026
8512097419!ADENOVIRUS TYPE 4 A
Department of Defense · $515,290 · May 11, 2026
8512097271!ADENOVIRUS TYPE 4 A
Department of Defense · $343,526 · May 11, 2026
8512097411!ADENOVIRUS TYPE 4 A
Department of Defense · $515,290 · May 11, 2026
8512042000!ADENOVIRUS TYPE 4 A
Department of Defense · $343,526 · Apr 15, 2026
8512042009!ADENOVIRUS TYPE 4 A
Department of Defense · $343,526 · Apr 15, 2026
8512041924!ADENOVIRUS TYPE 4 A
Department of Defense · $1,030,579 · Apr 15, 2026
8512042003!ADENOVIRUS TYPE 4 A
Department of Defense · $343,526 · Apr 15, 2026
8512042006!ADENOVIRUS TYPE 4 A
Department of Defense · $687,053 · Apr 15, 2026
8512042110!ADENOVIRUS TYPE 4 A
Department of Defense · $515,290 · Apr 15, 2026
8512042008!ADENOVIRUS TYPE 4 A
Department of Defense · $515,290 · Apr 15, 2026
8511984336!ADENOVIRUS TYPE 4 A
Department of Defense · $343,526 · Mar 18, 2026
8511984334!ADENOVIRUS TYPE 4 A
Department of Defense · $3,950,554 · Mar 18, 2026
8511918533!ADENOVIRUS TYPE 4 A
Department of Defense · $3,950,554 · Feb 17, 2026